Unknown

Dataset Information

0

Transcription profiling by array of human SK-MEL-2 cells infected with Ad-E2F-1 after treatment with doxorubicin


ABSTRACT: SK-MEL-2 cells treated with Ad-E2F-1 (MOI 2), Ad-E2F-1 (MOI 2)plus doxorubicin 0.1uM, or Ad-LacZ (MOI 2) plus doxorubicin 0.1uM. The combination of E2F-1 gene therapy and chemotherapy produces a synergistic effect on melanoma cell apoptosis. However, the molecular mechanisms have not been fully elucidated. The purpose of this study was to identify novel genes or pathways that may play key roles in apoptosis when E2F-1 gene therapy is combined with doxorubicin chemotherapy. MATERIALS AND METHODS: SK-MEL-2 melanoma cells were infected with Ad-E2F-1 alone, Ad-E2F-1 plus doxorubicin, or Ad-LacZ plus doxorubicin. After 16 hours of treatment, the total RNA was extracted from these cells and subjected to microarray analysis. Quantitative real-time PCR was performed to confirm the microarray data. RESULTS: Our results showed that the combination treatment of Ad-E2F-1 and doxorubicin affected the expression of cytokines, transcription factors, as well as genes involved in signal transduction, cell cycle regulation and apoptosis. CONCLUSION: Our findings have identified, for the first time, novel molecular targets and pathways that led to apoptosis in melanoma cells when Ad-E2F-1 was combined with doxorubicin. The molecular information provided here will enhance further mechanistic studies.

ORGANISM(S): Homo sapiens

SUBMITTER: Hao H 

PROVIDER: S-ECPF-GEOD-2715 | biostudies-other | 2006 May-Jun

REPOSITORIES: biostudies-other

Similar Datasets

2005-06-03 | GSE2715 | GEO
| S-ECPF-GEOD-6817 | biostudies-other
| S-ECPF-GEOD-8742 | biostudies-other
| S-ECPF-GEOD-39870 | biostudies-other
| S-ECPF-MTAB-1643 | biostudies-other
2007-10-27 | E-GEOD-2715 | biostudies-arrayexpress
| S-ECPF-GEOD-7578 | biostudies-other
2008-06-15 | E-GEOD-6817 | biostudies-arrayexpress
2022-01-27 | E-MTAB-11399 | biostudies-arrayexpress